Yang Wang is a Partner in Simpson Thacher’s Corporate Department. His varied practice includes assisting private equity funds and corporate clients on mergers and acquisitions, corporate finance transactions and other general corporate matters. Yang was recognized as one of China’s Top 15 M&A Lawyers by Asian Legal Business in 2019 and 2018. Yang has also been recognized by Chambers Asia and The Legal 500 for his work in M&A and private equity. Yang speaks English and Mandarin Chinese.
Read Full Biography...
Work Highlights
- Apax, Blackstone Capital Partners, KKR Asia, Macquarie Capital, Primavera Capital and Warburg Pincus in various private equity investments in Greater China
- Ant Group in its Series C equity financing totaling US$14 billion
- New Frontier Corporation in its US$1.3 billion acquisition of United Family Healthcare
- Xpeng Motors in its Series C/C+ equity financing totaling more than US$1 billion
- China National Chemical Corporation in its acquisition of Syngenta AG for approximately US$43 billion
- Alibaba Group in its US$4.63 billion investment in Suning Commerce Group Limited and Suning’s US$2.2 billion investment in Alibaba Group
- Alibaba Group in its strategic new retail partnership with Starbucks in China
- Kuaidi Dache in its merger with Didi Dache
Accolades
-
Top 15 M&A Lawyers in China by Asian Legal Business (ALB) in 2019 and 2018
-
Top 15 Rising Lawyers in China by Asian Legal Business (ALB) in 2016
Education
-
University of Michigan Law School, 2008 J.D.
magna cum laude; Clarence Darrow Scholar; Article Editor, Michigan Law Review
-
University of Maryland, 2005 M.A. in Applied Mathematics
-
University of Maryland, 2001 B.S. in Mathematics and Computer Science
magna cum laude
-
University of Maryland, 2000 B.A. in Economics
summa cum laude
Yang Wang is a Partner in Simpson Thacher’s Corporate Department. His varied practice includes assisting private equity funds and corporate clients on mergers and acquisitions, corporate finance transactions and other general corporate matters.
Recent representative experience includes advising:
- Apax, Blackstone Capital Partners, KKR Asia, Macquarie Capital, Primavera Capital and Warburg Pincus in various private equity investments in Greater China
- Ant Group in its Series C equity financing totaling US$14 billion
- New Frontier Corporation in its US$1.3 billion acquisition of United Family Healthcare
- Xpeng Motors in its Series C/C+ equity financing totaling more than US$1 billion
- China National Chemical Corporation in its acquisition of Syngenta AG for approximately US$43 billion
- Alibaba Group in its US$4.63 billion investment in Suning Commerce Group Limited and Suning’s US$2.2 billion investment in Alibaba Group
- Alibaba Group in its strategic new retail partnership with Starbucks in China
- Kuaidi Dache in its strategic stock-for-stock merger with Didi Dache
Yang was recognized by Asian Legal Business as one of China’s Top 15 M&A Lawyers in 2019 and 2018. Yang has also been recognized by Chambers Asia and The Legal 500 for his work in M&A and private equity.
Yang received his Bachelor’s degree in Economics, summa cum laude, and Bachelor’s degree in Mathematics and Computer Science, magna cum laude, from the University of Maryland, College Park in 2000 and 2001, respectively. He received his Juris Doctor degree, magna cum laude, from the University of Michigan Law School in 2008, where he was a Clarence Darrow Scholar and served as an Article Editor of the Michigan Law Review. Yang is admitted to practice law in the State of New York. He speaks English and Mandarin Chinese.